- Home
- ZUMZ vs FATE Comparison
ZUMZ vs FATE Comparison
Compare ZUMZ & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZUMZ
- FATE
- Stock Information
- Founded
- ZUMZ 1978
- FATE 2007
- Country
- ZUMZ United States
- FATE United States
- Employees
- ZUMZ N/A
- FATE N/A
- Industry
- ZUMZ Clothing/Shoe/Accessory Stores
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZUMZ Consumer Discretionary
- FATE Health Care
- Exchange
- ZUMZ Nasdaq
- FATE Nasdaq
- Market Cap
- ZUMZ 401.1M
- FATE 406.5M
- IPO Year
- ZUMZ 2005
- FATE 2013
- Fundamental
- Price
- ZUMZ $20.42
- FATE $1.82
- Analyst Decision
- ZUMZ Hold
- FATE Hold
- Analyst Count
- ZUMZ 2
- FATE 10
- Target Price
- ZUMZ $22.00
- FATE $6.75
- AVG Volume (30 Days)
- ZUMZ 306.3K
- FATE 3.8M
- Earning Date
- ZUMZ 12-05-2024
- FATE 11-12-2024
- Dividend Yield
- ZUMZ N/A
- FATE N/A
- EPS Growth
- ZUMZ N/A
- FATE N/A
- EPS
- ZUMZ N/A
- FATE N/A
- Revenue
- ZUMZ $891,864,000.00
- FATE $13,447,000.00
- Revenue This Year
- ZUMZ $4.32
- FATE N/A
- Revenue Next Year
- ZUMZ $2.19
- FATE N/A
- P/E Ratio
- ZUMZ N/A
- FATE N/A
- Revenue Growth
- ZUMZ 2.07
- FATE N/A
- 52 Week Low
- ZUMZ $12.90
- FATE $1.82
- 52 Week High
- ZUMZ $31.37
- FATE $8.83
- Technical
- Relative Strength Index (RSI)
- ZUMZ 43.75
- FATE 38.47
- Support Level
- ZUMZ $19.47
- FATE $2.35
- Resistance Level
- ZUMZ $22.22
- FATE $2.07
- Average True Range (ATR)
- ZUMZ 1.35
- FATE 0.32
- MACD
- ZUMZ -0.24
- FATE -0.07
- Stochastic Oscillator
- ZUMZ 23.63
- FATE 3.73
About ZUMZ Zumiez Inc.
Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.